A2 Infant Formula Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

Description

Persistence Market Research presents a comprehensive report on the global A2 Infant Formula Market, offers a comprehensive understanding of the A2 milk-based infant formula industry, including insights into market dynamics, growth drivers, challenges, and emerging trends. This report presents exclusive data and statistics forecasting the market trajectory from 2023 to 2030.

The global A2 infant formula market is forecast to expand at a CAGR of 15.0% and thereby increase from a value of US$843.9 Mn in 2023, to US$2,244.7 Mn by the end of 2030.

Key Insights:

A2 Infant Formula Market Size (2023E): US$843.9 Mn

Projected Market Value (2030F): US$2,244.7 Mn

Global Market Growth Rate (CAGR 2023 to 2030): 15.0%

Historical Market Growth Rate (CAGR 2018 to 2022): 12%

A2 Infant Formula Market - Report Scope:

A2 infant formula is derived from milk containing only the A2 beta-casein protein, which is believed to be easier to digest compared to A1 beta-casein protein found in conventional cow's milk. The A2 infant formula market caters to infants who may experience discomfort or digestive issues with traditional formulas, offering a gentler alternative. Market growth is driven by increasing awareness of infant nutrition, rising consumer demand for natural and organic products, and advancements in dairy processing technologies. The A2 infant formula segment represents a niche market within the broader infant nutrition landscape, catering to specific dietary preferences and nutritional requirements.

Market Growth Drivers:

The global A2 infant formula market is primarily driven by growing consumer awareness regarding the potential benefits of A2 milk, including easier digestion and reduced risk of digestive discomfort. Increasing prevalence of lactose intolerance, cow's milk protein allergy, and gastrointestinal issues among infants has propelled demand for alternative milk sources, driving adoption of A2 infant formula. Moreover, rising concerns regarding food allergies, intolerance, and sensitivities have led parents to seek natural and hypoallergenic nutrition options for their infants, further fueling market growth. Strategic marketing initiatives, product innovation, and regulatory approvals have also contributed to the expansion of the A2 infant formula market worldwide.

Market Restraints:

Despite favorable growth prospects, the A2 infant formula market faces challenges related to regulatory compliance, quality control, and supply chain management. Stringent regulatory standards governing infant formula composition, labeling, and safety require manufacturers to adhere to strict quality assurance protocols and undergo rigorous testing and certification processes. Additionally, ensuring consistent availability of A2 milk sources, maintaining product integrity throughout processing and distribution, and managing price competitiveness pose operational challenges for market participants. Addressing these challenges necessitates collaboration across the value chain to ensure product safety, regulatory compliance, and consumer trust in A2 infant formula products.

Market Opportunities:

The A2 infant formula market presents significant growth opportunities driven by expanding consumer demographics, increasing disposable incomes, and rising health consciousness among parents worldwide. Emerging markets, particularly in Asia-Pacific and Latin America, offer untapped potential for market expansion, driven by rising birth rates, urbanization, and changing lifestyles. Moreover, strategic partnerships, acquisitions, and investments in research and development enable market players to introduce innovative A2 infant formula products tailored to regional preferences and nutritional needs. Capitalizing on evolving consumer trends, such as organic, non-GMO, and clean label formulations, further enhances market competitiveness and sustains long-term growth in the dynamic A2 infant formula market landscape.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the A2 infant formula market globally?
Which regions and demographic segments are driving adoption of A2 infant formula?
How are regulatory dynamics, consumer preferences, and competitive landscapes shaping the A2 infant formula market?
Who are the key players contributing to the A2 infant formula market, and what strategies are they employing to maintain market leadership?
What are the emerging trends and future prospects in the global A2 infant formula market?

Competitive Intelligence and Business Strategy:

Leading players in the global A2 infant formula market, including The a2 Milk Company Limited, Synlait Milk, and Bubs Australia Limited, focus on product innovation, brand positioning, and strategic alliances to gain a competitive edge. These companies invest significantly in research and development to enhance product formulations, nutritional profiles, and sensory attributes, catering to evolving consumer preferences and regulatory requirements. Strategic partnerships with dairy farmers, supply chain optimization, and investments in sustainable sourcing practices strengthen brand credibility and supply chain resilience. Moreover, emphasis on consumer education, healthcare professional engagement, and digital marketing initiatives enhances brand awareness, fosters consumer trust, and drives market penetration in the highly competitive A2 infant formula market landscape.

Key Companies Profiled:
The A2 Milk Company
Synlait Milk
Bubs Australia Limited
Care A2+
Bellamy's Organic
Abbott
Mead Johnson
Perrigo

A2 Infant Formula Market Research Segmentation:

The A2 infant formula market encompasses a diverse Age Group, Form, and distribution channels, catering to varying nutritional needs and consumer preferences.

By Age Group:

Infant formula (0 to 6 months)

Follow-on formula (6 to 12 months)

Growing-up formula (12 to 36 months)

By Form:
Powder
Liquid
Semi-liquid
By Distribution Channel:
Hypermarket or Supermarket
Convenience Stores
Departmental Stores
Wholesale Stores

Specialty Health and Wellness stores

Independent Retailers
Specialty Stores
Pharmacies and Drugstores
Online Retailers
By Region:
North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33698

1. Executive Summary

1.1. Global A2 Infant Formula Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Age Group Lifecycle Analysis
2.4. A2 Infant Formula Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Form Landscape

3. Global A2 Infant Formula Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global A2 Infant Formula Market Outlook: Age Group
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Age Group, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Age Group, 2023 - 2030
  - 3.3.3.1. Infant formula (0 to 6 months)
  - 3.3.3.2. Follow-on formula (6 to 12 months)
  - 3.3.3.3. Growing-up formula (12 to 36 months)
3.4. Market Attractiveness Analysis: Age Group
3.5. Global A2 Infant Formula Market Outlook: Form
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Form, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Form, 2023 - 2030
  - 3.5.3.1. Powder
  - 3.5.3.2. Liquid
  - 3.5.3.3. Semi-liquid
3.6. Market Attractiveness Analysis: Form
3.7. Global A2 Infant Formula Market Outlook: Distribution Channel
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
  - 3.7.3.1. Hypermarket or Supermarket
  - 3.7.3.2. Convenience Stores
  - 3.7.3.3. Departmental Stores
  - 3.7.3.4. Wholesale Stores
  - 3.7.3.5. Specialty Health and Wellness stores
  - 3.7.3.6. Independent Retailers
  - 3.7.3.7. Specialty Stores
  - 3.7.3.8. Pharmacies and Drugstores
  - 3.7.3.9. Online Retailers
3.8. Market Attractiveness Analysis: Distribution Channel

4. Global A2 Infant Formula Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America A2 Infant Formula Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Age Group
- 5.3.3. By Form
- 5.3.4. By Distribution Channel
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Age Group, 2023 - 2030
- 5.5.1. Infant formula (0 to 6 months)
- 5.5.2. Follow-on formula (6 to 12 months)
- 5.5.3. Growing-up formula (12 to 36 months)
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Form, 2023 - 2030
- 5.6.1. Powder
- 5.6.2. Liquid
- 5.6.3. Semi-liquid
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 5.7.1. Hypermarket or Supermarket
- 5.7.2. Convenience Stores
- 5.7.3. Departmental Stores
- 5.7.4. Wholesale Stores
- 5.7.5. Specialty Health and Wellness stores
- 5.7.6. Independent Retailers
- 5.7.7. Specialty Stores
- 5.7.8. Pharmacies and Drugstores
- 5.7.9. Online Retailers
5.8. Market Attractiveness Analysis

6. Europe A2 Infant Formula Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Age Group
- 6.3.3. By Form
- 6.3.4. By Distribution Channel
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkiye
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Age Group, 2023 - 2030
- 6.5.1. Infant formula (0 to 6 months)
- 6.5.2. Follow-on formula (6 to 12 months)
- 6.5.3. Growing-up formula (12 to 36 months)
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Form, 2023 - 2030
- 6.6.1. Powder
- 6.6.2. Liquid
- 6.6.3. Semi-liquid
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 6.7.1. Hypermarket or Supermarket
- 6.7.2. Convenience Stores
- 6.7.3. Departmental Stores
- 6.7.4. Wholesale Stores
- 6.7.5. Specialty Health and Wellness stores
- 6.7.6. Independent Retailers
- 6.7.7. Specialty Stores
- 6.7.8. Pharmacies and Drugstores
- 6.7.9. Online Retailers
6.8. Market Attractiveness Analysis

7. East Asia A2 Infant Formula Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Age Group
- 7.3.3. By Form
- 7.3.4. By Distribution Channel
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Age Group, 2023 - 2030
- 7.5.1. Infant formula (0 to 6 months)
- 7.5.2. Follow-on formula (6 to 12 months)
- 7.5.3. Growing-up formula (12 to 36 months)
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Form, 2023 - 2030
- 7.6.1. Powder
- 7.6.2. Liquid
- 7.6.3. Semi-liquid
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 7.7.1. Hypermarket or Supermarket
- 7.7.2. Convenience Stores
- 7.7.3. Departmental Stores
- 7.7.4. Wholesale Stores
- 7.7.5. Specialty Health and Wellness stores
- 7.7.6. Independent Retailers
- 7.7.7. Specialty Stores
- 7.7.8. Pharmacies and Drugstores
- 7.7.9. Online Retailers
7.8. Market Attractiveness Analysis

8. South Asia & Oceania A2 Infant Formula Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Age Group
- 8.3.3. By Form
- 8.3.4. By Distribution Channel
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Age Group, 2023 - 2030
- 8.5.1. Infant formula (0 to 6 months)
- 8.5.2. Follow-on formula (6 to 12 months)
- 8.5.3. Growing-up formula (12 to 36 months)
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Form, 2023 - 2030
- 8.6.1. Powder
- 8.6.2. Liquid
- 8.6.3. Semi-liquid
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 8.7.1. Hypermarket or Supermarket
- 8.7.2. Convenience Stores
- 8.7.3. Departmental Stores
- 8.7.4. Wholesale Stores
- 8.7.5. Specialty Health and Wellness stores
- 8.7.6. Independent Retailers
- 8.7.7. Specialty Stores
- 8.7.8. Pharmacies and Drugstores
- 8.7.9. Online Retailers
8.8. Market Attractiveness Analysis

9. Latin America A2 Infant Formula Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Age Group
- 9.3.3. By Form
- 9.3.4. By Distribution Channel
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Age Group, 2023 - 2030
- 9.5.1. Infant formula (0 to 6 months)
- 9.5.2. Follow-on formula (6 to 12 months)
- 9.5.3. Growing-up formula (12 to 36 months)
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Form, 2023 - 2030
- 9.6.1. Powder
- 9.6.2. Liquid
- 9.6.3. Semi-liquid
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 9.7.1. Hypermarket or Supermarket
- 9.7.2. Convenience Stores
- 9.7.3. Departmental Stores
- 9.7.4. Wholesale Stores
- 9.7.5. Specialty Health and Wellness stores
- 9.7.6. Independent Retailers
- 9.7.7. Specialty Stores
- 9.7.8. Pharmacies and Drugstores
- 9.7.9. Online Retailers
9.8. Market Attractiveness Analysis

10. Middle East & Africa A2 Infant Formula Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Age Group
- 10.3.3. By Form
- 10.3.4. By Distribution Channel
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Age Group, 2023 - 2030
- 10.5.1. Infant formula (0 to 6 months)
- 10.5.2. Follow-on formula (6 to 12 months)
- 10.5.3. Growing-up formula (12 to 36 months)
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Form, 2023 - 2030
- 10.6.1. Powder
- 10.6.2. Liquid
- 10.6.3. Semi-liquid
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 10.7.1. Hypermarket or Supermarket
- 10.7.2. Convenience Stores
- 10.7.3. Departmental Stores
- 10.7.4. Wholesale Stores
- 10.7.5. Specialty Health and Wellness stores
- 10.7.6. Independent Retailers
- 10.7.7. Specialty Stores
- 10.7.8. Pharmacies and Drugstores
- 10.7.9. Online Retailers
10.8. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Powder
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. The A2 Milk Company
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Synlait Milk
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. Bubs Australia Limited.
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Care A2+
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. Bellamy's Organic
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Abbott
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Mead Johnson
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Product
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. Perrigo
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Product
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations